Search

Your search keyword '"Shiizaki K"' showing total 102 results

Search Constraints

Start Over You searched for: Author "Shiizaki K" Remove constraint Author: "Shiizaki K"
102 results on '"Shiizaki K"'

Search Results

Catalog

Books, media, physical & digital resources

3. Mineral and bone disease - CKD 1-5

9. Plasma Exchange for the Treatment of Human T-Cell Lymphotropic Virus Type 1 Associated Myelopathy

11. Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease

13. Abortion in AhR-knockout mice and fetomaternal immunity.

14. Attenuation of Bone Mineral Density Decline During Anemia Treatment With Methenolone Acetate in Myelodysplastic Syndrome.

15. Effect of denosumab on bone mineral density in a postmenopausal osteoporotic woman with prolonged chronic mild hyponatremia.

16. Removal of calciprotein particles from the blood using an adsorption column improves prognosis of hemodialysis miniature pigs.

19. Correlative light and electron microscopic observation of calcium phosphate particles in a mouse kidney formed under a high-phosphate diet.

20. Romosozumab improves low bone mineral density in a postmenopausal woman undergoing chronic hemodialysis and treated with a calcium-sensing receptor agonist.

21. Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression.

22. Bone responsiveness to parathyroid hormone is negatively associated with parathyroid hormone-lowering drug use in patients undergoing hemodialysis: a cross-sectional study.

23. Construction of reporter gene assays using CWP and PDR mutant yeasts for enhanced detection of various sex steroids.

24. Interleukin-36α as a potential biomarker for renal tubular damage induced by dietary phosphate load.

25. Calciprotein particles regulate fibroblast growth factor-23 expression in osteoblasts.

26. Comprehensive analysis of DNA adducts (DNA adductome analysis) in the liver of rats treated with 1,4-dioxane.

27. Postlabeling/PAGE Method for Detection of DNA Adducts.

28. Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation.

29. Insight into the relationship between aryl-hydrocarbon receptor and β-catenin in human colon cancer cells.

30. A decreased soluble Klotho level with normal eGFR, FGF23, serum phosphate, and FEP in an ADPKD patient with enlarged kidneys due to multiple cysts.

31. The impact of preserved Klotho gene expression on antioxidative stress activity in healthy kidney.

32. The Body-wide Transcriptome Landscape of Disease Models.

33. Biological and Clinical Effects of Calciprotein Particles on Chronic Kidney Disease-Mineral and Bone Disorder.

34. Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease.

35. Influence of GSH S-transferase on the mutagenicity induced by dichloromethane and 1,2-dichloropropane.

36. Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease.

37. Modulation of benzo[a]pyrene-DNA adduct formation by CYP1 inducer and inhibitor.

38. Fibroblast growth factor 21, assisted by elevated glucose, activates paraventricular nucleus NUCB2/Nesfatin-1 neurons to produce satiety under fed states.

39. Development of yeast reporter assays for the enhanced detection of environmental ligands of thyroid hormone receptors α and β from Xenopus tropicalis.

40. [Role of parathyroid hormone in Klotho-FGF23 system].

41. Phosphate-Induced Renal Fibrosis Requires the Prolyl Isomerase Pin1.

42. Construction of sensitive reporter assay yeasts for comprehensive detection of ligand activities of human corticosteroid receptors through inactivation of CWP and PDR genes.

43. Association between Serum Soluble Klotho Levels and Mortality in Chronic Hemodialysis Patients.

44. Microbial metabolites of omeprazole activate murine aryl hydrocarbon receptor in vitro and in vivo.

45. Development of yeast reporter assay for screening specific ligands of retinoic acid and retinoid X receptor subtypes.

46. Identification of amino acid residues in the ligand-binding domain of the aryl hydrocarbon receptor causing the species-specific response to omeprazole: possible determinants for binding putative endogenous ligands.

47. ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice.

48. Pin1 null mice exhibit low bone mass and attenuation of BMP signaling.

49. Dioxin suppresses benzo[a]pyrene-induced mutations and DNA adduct formation through cytochrome P450 1A1 induction and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide inactivation in human hepatoma cells.

50. Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.